Showing 1 to 1 of 1 results
smh.com.au
🌐 85% Global Worthiness


AI-Developed Drug Shows Promise in Cardiovascular Disease Treatment
Algorae Pharmaceuticals' AI-168 drug combination, partly involving cannabidiol, has shown significant promise in pre-clinical in-vitro studies to improve on existing treatments for cardiovascular disease, outperforming beta-blockers in three cell line models and leading to an international patent ap...
AI-Developed Drug Shows Promise in Cardiovascular Disease Treatment
Algorae Pharmaceuticals' AI-168 drug combination, partly involving cannabidiol, has shown significant promise in pre-clinical in-vitro studies to improve on existing treatments for cardiovascular disease, outperforming beta-blockers in three cell line models and leading to an international patent ap...
Progress
56% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results